SMTL ID : 8piy.1

NMR2 Structure of KRAS G12V (GMPPNP bound) in complex with (2E)-3-(1H-indol-2-yl)prop-2-enoic acid

Coordinates

PDB Format Compare

Method

SOLUTION NMR

Oligo State

monomer

Ligands

1 x Z5I: (~{E})-3-(1~{H}-indol-3-yl)prop-2-enoic acid(Non-covalent)

Z5I.1: 10 residues within 4Å: Chain A: K.5, L.6, V.7, S.39, D.54, I.55, L.56, Y.71, T.74, G.75 10 PLIP interactions: 10 interactions with chain A Hydrophobic interactions: A:K.5, A:V.7, A:L.56, A:L.56, A:Y.71 Hydrogen bonds: A:K.5, A:S.39, A:D.54 pi-Cation interactions: A:K.5, A:K.5

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Butikofer, M. et al., NMR2-Based Drug Discovery Pipeline Presented on the Oncogenic Protein KRAS. J.Am.Chem.Soc. (2025)

Release Date

2024-07-10

Peptides

RASK GTPase (Fragment): A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

RASK GTPase (Fragment)

Related Entries With Identical Sequence